Xiuli Zuo, PhD,MD
Qilu Hospital of Shandong University
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Li Yanqing, MD, PhD
Qilu Hospital of Shandong University
Shared therapeutic areas:
Worked with same sponsors:
xiaojiao Li
The First Hospital of Jilin University
Shared therapeutic areas:
David Y Graham, MD
Baylor College of Medicine
Shared therapeutic areas:
Xiuli Zuo, MD,PhD
Qilu Hospital of Shandong University
Shared therapeutic areas:
Worked with same sponsors:
Eun Jung Jeon
The Catholic University of Korea
Shared therapeutic areas:
Jyh-Ming Liou, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Ming-Cheh CHEN, MD
Buddhist Tzu Chi General Hospital
Shared therapeutic areas:
Il Ju Choi, M.D., Ph.D.
National Cancer Center, Korea
Shared therapeutic areas:
Ming-Shiang Wu, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Jyh-Chin Yang, M.D.Ph.D.
National Taiwan University Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
All 3 trials loaded